Oncology & Cancer

Improving access to early-stage lung cancer care in Europe

There are stark differences between European countries when it comes to both the reimbursement of, and access to, new treatments for patients with early-stage lung cancer. There are also differences in reimbursement times ...

Oncology & Cancer

Combining CAR-T cells and inhibitor drugs for high-risk neuroblastoma

Chimeric antigen receptor (CAR)-T cell therapy is a potent emerging weapon against cancer, altering patients' T cells so they can better find and destroy tumor cells. But CAR-T cell therapy doesn't work well in every cancer—including ...

Diseases, Conditions, Syndromes

Sickle cell and COVID-19: A risky mix of two diseases

UdeM's Stéphanie Forté and co-researchers in Canada and Brazil have shown how people with sickle cell disease or sickle cell trait have a higher chance of dying from COVID-19 than the general population.

Psychology & Psychiatry

Is ketamine an antidepressant, wellness trend or dangerous drug?

When an autopsy revealed that actor Matthew Perry died of "acute effects of ketamine," it put fresh attention on an ongoing debate in the field of psychiatry: What's the right balance between expanding access to a drug that ...

page 10 from 40